Author Question: Why is an infusion of muromonab-CD3 (Orthoclone) more likely to result in an allergic reaction than ... (Read 78 times)

azncindy619 · **on:** Jul 23, 2018

Why is an infusion of muromonab-CD3 (Orthoclone) more likely to result in an allergic reaction than an infusion of mycophenolate (CellCept)?

a. Muromonab-CD3 is administered for shorter time periods than is mycophenolate.
b. Muromonab-CD3 is administered in much higher dosages than is mycophenolate.
c. Mycophenolate is an antiproliferative agent and muromonab-CD3 is a polyclonal antibody.
d. Mycophenolate is a synthetically manufactured drug and muromonab-CD3 is produced using mouse proteins.

Question 2

Which precaution is most important to teach a patient taking an antiproliferative agent to manage an autoimmune disease?

a. Do not stop taking this drug for any reason or your organs will become atrophied.
b. Keep all health care appointments because your risk for cancer is now increased.
c. Avoid foods and drinks containing caffeine because your risk for high blood pressure is greatly increased.
d. Make certain someone is with you when you take this drug because allergic reactions are common and often delayed.